Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ICVX
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Icosavax Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 769.04M
- Ent value
- 724.71M
- Price/Sales
- -
- Price/Book
- 3.31
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 87.16%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
ICVX does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 3.31 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 50.23M |
| EPS (TTM) | -1.85 |
| FCF per share (TTM) | -1.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -3.67M |
| Operating income (TTM) | -105.88M |
| Net income (TTM) | -92.62M |
| EPS (TTM) | -1.85 |
| EPS (1y forward) | -2.07 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 63.24M |
| Net receivables | 0.00 |
| Total current assets | 235.31M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 14.38M |
| Total assets | 251.30M |
| Accounts payable | 1.24M |
| Short/Current long term debt | 8.07M |
| Total current liabilities | 13.03M |
| Total liabilities | 18.92M |
| Shareholder's equity | 232.38M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -68.85M |
| Capital expenditures (TTM) | 4.83M |
| Free cash flow (TTM) | -73.68M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -39.86% |
| Return on Assets | -36.86% |
| Return on Invested Capital | -39.48% |
| Cash Return on Invested Capital | -31.41% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ICVX | S&P500 | |
| Current price drop from All-time high | -61.96% | - |
| Highest price drop | -94.24% | -56.47% |
| Date of highest drop | 14 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -68.69% | -11.07% |
| Avg time to new high | 72 days | 12 days |
| Max time to new high | 634 days | 1805 days |
COMPANY DETAILS
Marketcap
769.04M
Marketcap category
Small-cap
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc. operates as a subsidiary of AstraZeneca PLC.
Employees
60
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner